MNDA Antikörper (FITC)
| Antigen |
|
| Klonalität |
Monoklonal (3C1) |
|
Wirt
|
|
|
Konjugat
|
FITC
|
|
Applikation
|
Alternativen Durchflusszytometrie (FACS), Fluoreszenzmikroskopie (FM), In situ-Hybridisierung (ISH)
|
| Produktnummer |
ABIN648953 |
| Menge |
1 ml |
| Preis |
415,71 € Zzgl. Versandkosten €20,00 und MWSt
|
| Lieferung nach |
|
| Verfügbarkeit |
Lieferung in 5 bis 7 Werktagen |
|
Isotyp
|
IgG1 kappa
|
|
Klon
|
3C1
|
|
Beschreibung
|
Antigen distribution: The antibody reacts to the human myeloid nuclear differentiation antigen (MNDA). Cross reactivity to a similar protein in other species has not been extensively characterized. Most applications will require permeabilization or solubilization of cell membranes, as the primary cell localization of this protein is intranuclear [1]. MNDA has been characterized as a cofactor in regulation of cell cycle progression, cell differentiation and apoptosis [2-4]. The human myeloid nuclear differentiation antigen, MNDA, is expressed only in myelomonocytic and a subset of B lymphoid hematopoietic cells [5]. MNDA is uniformly distributed throughout the interphase cell nucleus and associates with chromatin, but does not bind specific DNA sequences [6]. It is a member of the interferon-alpha inducible protein family and accordingly has been reported to be altered in a variety of inflammatory related disease states [3, 7- 11]. Expression is disproportionately consistent in the marginal zone lymphoproliferative disorders subset of malignant lymphoma [12]. Expression is reported to be decreased in myelodysplasia in myeloid precursors and mature forms [13, 14].45-15 is suitable for intracellular staining of cytospots and frozen tissue sections by immunohistochemistry. Cellular Expression: nuclear protein expressed by myeloid cells and a subset of B-cells.
|
|
Spezifität
|
Concentrated nuclear protein extract prepared from late stage human myeloid leukemia HL-60 cells..45-15 produces mouse IgG1 immunoglobulins directed against human IFN-γ [1-4]. It is generally advisable to use a specificity control such as one of the following: 1) unlabeled antibody, 2) recombinant cytokines or 3) mouse isotype control
|
Alternativen zu Antigen "MNDA", Typ "Antikörper" finden
|
Wirte
|
Kaninchen (8), Maus (4), Ratte (1)
|
|
Reaktivitäten
|
Human (11)
|
|
Applikationen
|
Western Blot (WB) (9), Immunhistochemie (Paraffinschnitte) (IHC (p)) (4), ELISA (3), Enzyme Immunoassay (EIA) (3), ELISA (Detektionsantikörper) (2), Durchflusszytometrie (FACS) (1), Fluoreszenzmikroskopie (FM) (1), Immunhistochemie (IHC) (1), In situ-Hybridisierung (ISH) (1)
|